NEW YORK — The US National Institutes of Health said on Monday that it has launched a clinical study aimed at understanding the effects of SARS-CoV-2 in children.
According to the NIH, the study — called Human Epidemiology and Response to SARS-CoV-2, or HEROS — is focused on determining what percentage of children infected with the virus develop symptoms of COVID-19. It will also examine whether rates of SARS-CoV-2 infection differ between healthy children and ones with asthma or other allergic conditions.